Covid-19 : les confinements ont eu un impact délétère sur la sévérité du cancer colorectal métastatique

These contents could be interesting :

A new antibody-drug conjugate shows promising results in metastatic breast cancer

A new study, published in Nature Medicine, highlights the efficacy of patritumab deruxtecan (HER3-DXd), an antibody HER3-directed-drug conjugate (ADC), in patients with hormone receptor-positive metastatic breast cancer who had....

Pancreatic cancer: an antibody proves itself in an early clinical trial

Pancreatic cancer, which affects a growing number of patients, remains one of the most aggressive forms due to the ability of cancer cells to resist traditional treatments such as....

Medias

Researcher Contact

Alain Thierry

Inserm U1194

e-mail : rf.mresni@yrreiht.niala

Téléphone sur demande

Press Contact

rf.mresni@esserp

Sources

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer

Thierry AR, Pastor B, Pisareva E, et al.

JAMA Network Open, septembre 2021

DOI : 10.1001/jamanetworkopen.2021.24483